[Role of erythrocyte chalone in regulating erythropoiesis].
D000818:Animals; D000970:Antineoplastic Agents; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D004247:DNA / Q000096:biosynthesis; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000378:metabolism / Q000502:physiology*; D004920:Erythropoiesis / Q000187:drug effects; D006131:Growth Inhibitors / Q000097:blood / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D011087:Polycythemia Vera / Q000188:drug therapy; D051381:Rats; D011956:Receptors, Cell Surface / Q000032:analysis; D018000:Receptors, Peptide
D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D011956:Receptors, Cell Surface; D018000:Receptors, Peptide; C031544:chalone receptor; D004247:DNA
O roli éritrotsitarnogo keilona v reguliatsii éritropoéza.